Juul gets FDA's OK to keep selling tobacco and menthol e-cigarettes
FDA regulators said Thursday that Juul's studies show its e-cigarettes are less harmful for adult smokers, who can benefit from switching completely to vaping.
The FDA decision applies to both tobacco- and menthol-flavored versions of the reusable product, which works with nicotine-filled cartridges sold in two different strengths. Juul previously discontinued several fruit and candy flavors that helped drive its popularity but were favored by teens.
Juul will be one of only two U.S. companies authorized to sell menthol-flavored vapes, which many adults prefer to tobacco flavor.
'This is an important milestone for the company and I think we made a scientifically sound case for the role that menthol can play in e-vapor,' Juul CEO K.C. Crosthwaite told The Associated Press.
Parents, politicians and anti-tobacco groups are certain to oppose FDA's decision. They have argued for years that Juul products should be permanently banned due to their role in triggering a yearslong spike in underage vaping.
'It is a big step in the wrong direction to authorize sales of the product that was responsible for this public health crisis in the first place,' said Yolonda Richardson, CEO of the Campaign for Tobacco-Free Kids in a statement.
Juul was once valued at over $13 billion and its small, sleek e-cigarettes revolutionized the image and technology of the vaping industry. But the company has since been forced to slash hundreds of jobs and pay billions to settle lawsuits over its role in the rise of youth vaping.
The FDA had ordered the company to remove its products from the market in June 2022. But then the agency abruptly reversed course days later and agreed to reopen its scientific review of Juul's application after the company pushed back in court.
Juul said that regulators had overlooked thousands of pages of scientific data critical to its submission.
Thursday's announcement is not an approval or endorsement, and the FDA reiterated that people who do not smoke should not use Juul or any other e-cigarettes. The FDA determination indicates that smokers who switch completely to Juul can reduce their exposure to deadly carcinogens and other chemicals found in traditional cigarettes.
The FDA decision applies to Juul's original system, which is now roughly a decade old. Crosthwaite said the company hopes to win authorization for its next-generation device and is also considering applying to FDA for more flavors.
'It's critically important that American adults who use tobacco have regulated options,' Crosthwaite said.
In recent years, the FDA has authorized a handful of e-cigarettes to help adult smokers cut back on cigarettes. Juul's main competitors, Vuse and Njoy, each previously received FDA permission to remain on the market. Njoy sells the only other menthol-flavored e-cigarettes authorized by FDA.
To meet FDA requirements, companies must show that their products benefit public health. In practice, that means proving that adult smokers who use them are likely to quit or reduce their smoking, while teens are unlikely to get hooked on them.
The brainchild of two Stanford University students, Juul launched in 2015 and within two years rocketed to the top of the vaping market.
Juul quickly outpaced older brands with its high-nicotine, fruity-flavored cartridges, sold in mango, mint and creme brulé. The company's small, discrete devices provided a more potent, user-friendly alternative to older, bulkier devices.
But the company's rise was fueled by underage use, and e-cigarettes quickly became ubiquitous in U.S. schools. In 2019, the company was pressured into halting all advertising and eliminating most of its flavors, leaving only tobacco and menthol-flavored options.
By then the company was already the target of multiple investigations and lawsuits by federal, state and local officials as well as class action attorneys.
In 2022, the company paid $1.7 billion to settle thousands of lawsuits brought by families of Juul users, school districts, city governments and Native American tribes. The company separately agreed to pay $1.1 billion to settle lawsuits or investigations from most U.S. states.
Juul is no longer the top-selling e-cigarette brand and now trails Vuse, which is sold by tobacco giant Reynolds American, which also makes Camel and Newport cigarettes.
Teens have shifted away from Juul amid a wider drop in vaping, according to the latest federal figures. The FDA reported last year that teen vaping dropped to a 10-year low, after stepped up enforcement against unauthorized brands imported from China, such as Elf Bar.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 minutes ago
- Yahoo
Tesla Awards Musk $29 Billion in Shares as 2018 Pay Battle Continues
Tesla (TSLA, Financials) granted CEO Elon Musk an interim award of 96 million shares, valued at about $29 billion, while his disputed $56 billion 2018 compensation package remains under review by the Delaware Supreme Court. The award will vest in two years if Musk stays as CEO or in another top role. It will be forfeited if the court clears the 2018 package, which was previously struck down by a Delaware judge as improperly approved. Shareholders re?approved that plan in June 2024. The move follows Tesla's weak quarterly results, with sales falling for a second straight quarter and automotive revenue down 16%. Musk warned of possible rough quarters ahead as EV tax credit cuts loom. The company will hold another shareholder meeting in November. This article first appeared on GuruFocus.
Yahoo
5 minutes ago
- Yahoo
Kyndryl (NYSE:KD) Misses Q2 Sales Targets, Stock Drops 13%
IT infrastructure services provider Kyndryl (NYSE:KD) fell short of the market's revenue expectations in Q2 CY2025, with sales flat year on year at $3.74 billion. Next quarter's revenue guidance of $3.81 billion underwhelmed, coming in 1.5% below analysts' estimates. Its non-GAAP profit of $0.37 per share was in line with analysts' consensus estimates. Is now the time to buy Kyndryl? Find out in our full research report. Kyndryl (KD) Q2 CY2025 Highlights: Revenue: $3.74 billion vs analyst estimates of $3.80 billion (flat year on year, 1.5% miss) Adjusted EPS: $0.37 vs analyst estimates of $0.36 (in line) Adjusted EBITDA: $647 million vs analyst estimates of $628 million (17.3% margin, 3% beat) Revenue Guidance for Q3 CY2025 is $3.81 billion at the midpoint, below analyst estimates of $3.87 billion Operating Margin: 4%, up from 2.5% in the same quarter last year Free Cash Flow was -$267 million compared to -$27.75 million in the same quarter last year Market Capitalization: $8.42 billion "Our first quarter reflected steady progress across key growth areas of our business, with contributions from Kyndryl Consult, hyperscaler-related activity, scope expansions and productivity gains. Our expertise in mission-critical technology and our unique operational capabilities, including Kyndryl Bridge, are helping customers innovate and creating new growth opportunities for Kyndryl," said Chairman and Chief Executive Officer Martin Schroeter. Company Overview Born from IBM's managed infrastructure services business in a 2021 spinoff, Kyndryl (NYSE:KD) is the world's largest IT infrastructure services provider that designs, builds, and manages technology environments for enterprise customers. Revenue Growth Examining a company's long-term performance can provide clues about its quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years. With $15.06 billion in revenue over the past 12 months, Kyndryl is a behemoth in the business services sector and benefits from economies of scale, giving it an edge in distribution. This also enables it to gain more leverage on its fixed costs than smaller competitors and the flexibility to offer lower prices. However, its scale is a double-edged sword because it's harder to find incremental growth when you've penetrated most of the market. To expand meaningfully, Kyndryl likely needs to tweak its prices, innovate with new offerings, or enter new markets. As you can see below, Kyndryl struggled to generate demand over the last five years. Its sales dropped by 4.6% annually, a tough starting point for our analysis. Long-term growth is the most important, but within business services, a half-decade historical view may miss new innovations or demand cycles. Kyndryl's recent performance shows its demand remained suppressed as its revenue has declined by 5.7% annually over the last two years. This quarter, Kyndryl's $3.74 billion of revenue was flat year on year, falling short of Wall Street's estimates. Company management is currently guiding for a 1% year-on-year increase in sales next quarter. Looking further ahead, sell-side analysts expect revenue to grow 3.4% over the next 12 months. While this projection implies its newer products and services will spur better top-line performance, it is still below the sector average. Software is eating the world and there is virtually no industry left that has been untouched by it. That drives increasing demand for tools helping software developers do their jobs, whether it be monitoring critical cloud infrastructure, integrating audio and video functionality, or ensuring smooth content streaming. Click here to access a free report on our 3 favorite stocks to play this generational megatrend. Operating Margin Although Kyndryl was profitable this quarter from an operational perspective, it's generally struggled over a longer time period. Its expensive cost structure has contributed to an average operating margin of negative 3.2% over the last five years. Unprofitable business services companies require extra attention because they could get caught swimming naked when the tide goes out. It's hard to trust that the business can endure a full cycle. On the plus side, Kyndryl's operating margin rose by 11.5 percentage points over the last five years. Still, it will take much more for the company to show consistent profitability. In Q2, Kyndryl generated an operating margin profit margin of 4%, up 1.5 percentage points year on year. This increase was a welcome development and shows it was more efficient. Earnings Per Share Revenue trends explain a company's historical growth, but the change in earnings per share (EPS) points to the profitability of that growth – for example, a company could inflate its sales through excessive spending on advertising and promotions. Kyndryl's full-year EPS flipped from negative to positive over the last two years. This is encouraging and shows it's at a critical moment in its life. In Q2, Kyndryl reported adjusted EPS at $0.37, up from $0.13 in the same quarter last year. This print beat analysts' estimates by 1.8%. Over the next 12 months, Wall Street expects Kyndryl's full-year EPS of $1.41 to grow 89.1%. Key Takeaways from Kyndryl's Q2 Results It was encouraging to see Kyndryl beat analysts' EPS expectations this quarter. On the other hand, its revenue slightly missed and its revenue guidance for next quarter fell short of Wall Street's estimates. Overall, this was a weaker quarter. The stock traded down 13% to $31.92 immediately after reporting. Kyndryl didn't show it's best hand this quarter, but does that create an opportunity to buy the stock right now? The latest quarter does matter, but not nearly as much as longer-term fundamentals and valuation, when deciding if the stock is a buy. We cover that in our actionable full research report which you can read here, it's free.
Yahoo
5 minutes ago
- Yahoo
BellRing Brands (NYSE:BRBR) Posts Better-Than-Expected Sales In Q2
Nutrition products company Bellring Brands (NYSE:BRBR) reported Q2 CY2025 results beating Wall Street's revenue expectations , with sales up 6.2% year on year to $547.5 million. The company expects the full year's revenue to be around $2.3 billion, close to analysts' estimates. Its non-GAAP profit of $0.55 per share was 9.9% above analysts' consensus estimates. Is now the time to buy BellRing Brands? Find out in our full research report. BellRing Brands (BRBR) Q2 CY2025 Highlights: Revenue: $547.5 million vs analyst estimates of $531.8 million (6.2% year-on-year growth, 3% beat) Adjusted EPS: $0.55 vs analyst estimates of $0.50 (9.9% beat) Adjusted EBITDA: $120.3 million vs analyst estimates of $112.6 million (22% margin, 6.8% beat) The company reconfirmed its revenue guidance for the full year of $2.3 billion at the midpoint EBITDA guidance for the full year is $485 million at the midpoint, below analyst estimates of $488 million Operating Margin: 8.2%, down from 21.7% in the same quarter last year Organic Revenue rose 6.2% year on year (15.6% in the same quarter last year) Sales Volumes rose 3.5% year on year (18.4% in the same quarter last year) Market Capitalization: $6.87 billion Company Overview Spun out of Post Holdings in 2019, Bellring Brands (NYSE:BRBR) offers protein shakes, nutrition bars, and other products under the PowerBar, Premier Protein, and Dymatize brands. Revenue Growth Reviewing a company's long-term sales performance reveals insights into its quality. Even a bad business can shine for one or two quarters, but a top-tier one grows for years. With $2.22 billion in revenue over the past 12 months, BellRing Brands is a small consumer staples company, which sometimes brings disadvantages compared to larger competitors benefiting from economies of scale and negotiating leverage with retailers. On the bright side, it can grow faster because it has a longer list of untapped store chains to sell into. As you can see below, BellRing Brands's sales grew at an impressive 18.6% compounded annual growth rate over the last three years as consumers bought more of its products. This quarter, BellRing Brands reported year-on-year revenue growth of 6.2%, and its $547.5 million of revenue exceeded Wall Street's estimates by 3%. Looking ahead, sell-side analysts expect revenue to grow 12% over the next 12 months, a deceleration versus the last three years. Still, this projection is admirable and suggests the market is forecasting success for its products. Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) stock benefiting from the rise of AI. Click here to access our free report one of our favorites growth stories. Volume Growth Revenue growth can be broken down into changes in price and volume (the number of units sold). While both are important, volume is the lifeblood of a successful staples business as there's a ceiling to what consumers will pay for everyday goods; they can always trade down to non-branded products if the branded versions are too expensive. To analyze whether BellRing Brands generated its growth from changes in price or volume, we can compare its volume growth to its organic revenue growth, which excludes non-fundamental impacts on company financials like mergers and currency fluctuations. Over the last two years, BellRing Brands's average quarterly volume growth of 20.1% has outpaced the competition by a long shot. In the context of its 19.5% average organic revenue growth, we can see that most of the company's gains have come from more customers purchasing its products. In BellRing Brands's Q2 2025, sales volumes jumped 3.5% year on year. This result was a meaningful deceleration from its historical levels. We'll be watching BellRing Brands closely to see if it can reaccelerate demand for its products. Key Takeaways from BellRing Brands's Q2 Results We enjoyed seeing BellRing Brands beat analysts' organic revenue growth, total revenue, and EBITDA expectations this quarter. That full-year revenue guidance was reaffirmed shows that the business is on track. Overall, we think this was a decent quarter with some key metrics above expectations. The stock remained flat at $54.00 immediately following the results. Indeed, BellRing Brands had a rock-solid quarterly earnings result, but is this stock a good investment here? We think that the latest quarter is just one piece of the longer-term business quality puzzle. Quality, when combined with valuation, can help determine if the stock is a buy. We cover that in our actionable full research report which you can read here, it's free.